Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhichuanling injection nebulization vs budesonide for asthmatic bronchitis in children
ChiCTR2300069215Phase 4Completed
- Sponsor
- Taizhou Jiangyan Traditional Chinese Medicine Hospital
- Start
- Oct 2022
- Countries
- 1
01
Overview
Phase 4, randomised trial of Zhichuanling in asthmatic bronchitis (2 arms), sponsored by Taizhou Jiangyan Traditional Chinese Medicine Hospital. Primary endpoint: Clinical symptom efficacy (control rate) at day 7. Started Oct 2022; status: completed.
02
Drugs
Zhichuanling
03
Conditions
asthmatic bronchitis
Beyond the preview
Go deeper on ChiCTR2300069215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069215.